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RESEARCH ARTICLE Open Access
Trends in hospital admissions due to
antidepressant-related adverse drug
events from 2001 to 2011 in the U.S.
Harish S. Parihar1*, Hongjun Yin1, Jennifer L. Gooch1, Shari Allen1, Samuel John1 and Jianwei Xuan2
Abstract
Background: Depression is a prevalent mental health disorder and the fourth leading cause of disability in the
world as per the World Health Organization. Use of antidepressants can lead to adverse drug events (ADEs), defined
as any injury resulting from medication use. This study aimed to examine changes in hospital admissions due to
antidepressant-related ADEs (ArADEs) among different socio-demographic groups and changes in lengths of stay
(LOS) and hospital charges in ArADE admissions from 2001 to 2011.
Methods: The Healthcare Cost and Utilization Project database was used. ArADE admissions in different socio-
demographic groups were examined including characteristics such as age, gender, rural/urban, and income.
LOS and hospital charges for ArADE cases were compared between 2001 and 2011. Chi-square test and t test were
used for statistical analyses.
Results: There were 17,375 and 20,588 ArADE related admissions in 2001 and 2011, respectively. There was a 17.6%
increase among the group of 18 to 64 years old and a 64.8% increase among the group of 65 years or older while the
other age groups experienced decreased admission rates. Males and females had similar increases. Patients from the
lower income areas experienced a two-fold increase while those from the higher income areas experienced a decrease.
The mean LOS for all ArADE related admissions increased from 2.18 to 2.81 days and mean hospital charges increased
from $8,456.2 to $21,572.5.
Conclusions: There was an increase in ArADE hospital admissions. The greater increase in ArADE admissions among
elderly, urban or low-income patients should be noted and addressed by practitioners and policy makers. The large
increase in hospital charges needs further research.
Keywords: Adverse drug events, Antidepressants, Hospital admissions, Healthcare Cost and Utilization Project database,
Medication errors
Background
Depression is a prevalent mental health disorder and the
fourth leading cause of disability in the world as per the
World Health Organization (WHO) [1]. Antidepressants
are the most common treatment options for depression.
In addition, antidepressants are also prescribed for
other conditions such as dysthymia, bipolar depression,
schizoaffective disorder, post-psychotic depression, gen-
eralized anxiety disorder, panic disorder, social phobia,
substance abuse disorders, anorexia, bulimia, obsessive
compulsive disorder, post-traumatic stress disorder, and
chronic pain syndromes [2]. The prevalence of anti-
depressant use has trended upwards in the United
States in the last decade. In 2000 about 6.5% of the
adult population in the US was treated with antidepres-
sants while 10.4% were prescribed the medications in
2010 [3]. Long-term users of antidepressants increased
from 3.0% to 6.9% over the same time period.
The Institute of Medicine defines adverse drug events
(ADEs) as any injury resulting from medication use [4].
The American Society of Health-System Pharmacists
(ASHP) defines a significant ADR as any unexpected,
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unintended, undesired, or excessive response to a drug
that requires discontinuation of the drug, changing the
drug therapy, modifying the dose, necessitates admission
to a hospital; prolongs stay in a health care facility, ne-
cessitates supportive treatment, significantly complicates
diagnosis, negatively affects prognosis or results in
temporary or permanent harm, disability, or death [5].
Severe adverse drug effects caused by antidepressants
may lead to mortality, including self-inflicted injuries,
myocardial infarction, stroke/transient ischemic attack,
falls, fractures, upper gastrointestinal bleeding, epilepsy/
seizures, and others [6]. In 2011, 89,000 emergency
room visits in the U.S were due to adverse drug events
(ADEs) related to psychiatric medications including anti-
depressants [7]. Although, not all ADEs are preventable,
there is data to support that approximately one-quarter
of all harmful ADEs are preventable [8]. Bates and
colleagues found that antidepressants are one of three
classes of medications that are significantly associated
with preventable ADEs among hospitalized patients [9].
The prevalence and incidence of ADEs may be related
to socio-demographic factors. Previous studies showed
that among the causes of emergency department visits
or hospitalizations, patients aged 65 years or older were
associated with higher rate of ADEs than younger pa-
tients [10]. A review by Tache et al on prevalence of
ADEs among ambulatory care patients showed that eld-
erly patients had higher prevalence rate than younger
adult patients, who had higher prevalence rate than
pediatrics patients [11]. Studies on the relationship
between other socio-demographic factors and ADEs are
scarce in the literature. This study aimed to examine
changes in incidence of hospital admissions due to
antidepressant-related ADEs (ArADEs) from 2001 to
2011 in the U.S., whether the changes are similar across
different age groups, if other socio-demographic factors
(sex, income, and urban/rural setting) influence any of
the observed changes in different age groups; and to
examine changes in lengths of stay (LOS) and hospital
charges in ArADE hospitalizations from 2001 to 2011.
Methods
A retrospective secondary data analysis was conducted
using Healthcare Cost and Utilization Project (HCUP)
National Inpatient Sample (NIS) database. This study
was approved by The Institutional Review Board of the
Philadelphia College of Osteopathic Medicine.
The HCUP is a family of databases sponsored by the
Agency for Health Research and Quality and covers
community hospitals from more than 40 states [12].
HCUP databases are derived from hospital administra-
tive data, which include diagnoses and procedures, dis-
charge status, patient demographics, and charges as well
as characteristics of the hospitals such as teaching status,
urban or rural location and size. We used the National
Inpatient Sample (NIS) data from the HCUP database.
The NIS data included inpatient care from all-payer hos-
pitals. After applying weights, the NIS data estimate
about 36 million hospitalizations nationally [13].
In the HCUP data, age was recorded in years and race
was categorized into six groups: white, black, Hispanic,
Asian and Pacific Islander, Native American, and other.
Location of a hospital was recorded as either rural or
urban. Median income of zip code of patient’s residence
was categorized into four quartiles.
Identification of ArADE admissions
ADEs are defined as any injury resulting from medica-
tion use. For this study, Illicit drug use and cases of
intentional harm or self-inflicted injury were excluded
(ICD codes E950.0-E950.9, Suicide and self-inflicted poi-
soning; E962.0-E962.9, Assault by poisoning; E980.0-
E980.9 Poisoning undetermined whether accidentally or
purposely inflicted). The HCUP database recorded up to
15 diagnoses in 2001 and up to 25 diagnoses in 2011 for
general ADE-associated diagnosis of each inpatient stay
record. The diagnoses were recorded in International
Statistical Classification of Diseases and Related Health
Problems, 9th revision (ICD-9) codes. The ICD-9 codes
used to identify ArADEs were retrieved from a report by
Lucado et al. [14]. Primary diagnoses of ArADE were
considered as an indicator of ArADE admissions.
Statistical analysis
Weights of individual inpatient stays provided in the
database were used to estimate the national total.
ArADEs in different socio-demographic groups were
examined including age, race, gender, rural/urban, and
median income in a patient’s residential area. Age was
categorized into 0 to 6, 7 to 17, 18 to 64, and 65 years or
older. LOS and hospital charges for ArADE cases were
compared between 2001 and 2011. Chi-square test was
used to compare changes in ADEs relative to the change
in total number of hospital admissions. Student’s T-test
was used to compare changes in LOS and hospital
charges. Given the highly skewed distribution of LOS
and hospital charges, the two variables were transformed
by taking square root before T-tests were conducted. A
p-value of ≤0.01 was considered statistically significant.
To more accurately reflect the changes in each subgroup
relative to the change in total ArADE admissions over
time, percentage changes in rates (rate was calculated as
ArADE admission in a subgroup divided by total ArADE
admissions in the corresponding year) for each subgroup
were also calculated (Table 1). To simplify the presenta-
tion for changes by age and income, patients from areas
with income in the lower two quartiles were lumped
together (“bottom-half”) and patients from areas with
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income in the upper two quartiles were lumped together
(“top-half”) (Table 3).
Results
Changes in number of ArADE admissions from 2001 to
2011 between different demographic groups are pre-
sented in Tables 1, 2, 3 and 4. Due to a large number of
records in 2001 that were missing race data, results on
changes of ArADE admissions by race are not presented.
There were 17,375 and 20,588 ArADE admissions in
2001 and 2011 respectively, this increase was statistically
significant (p < 0.01, Table 1). After excluding records
with missing data in age, sex, median income in a patient’s
residential zip code, or hospital setting (urban/rural), the
numbers were 17,072 and 19,688 for 2001 and 2011 re-
spectively and the result was still statistically significant.
The four age groups experienced different changes in
ArADE admissions (p < 0.01, Table 1). Specifically, ArADE
admissions in ≤6 years and 7–17 years old patients de-
creased 14.3% and 14.9% respectively. Conversely, the ad-
mission in the group of 18 to 64 years and ≥65 years
showed an increase of 17.6% and 64.8% respectively. Rates
for ≤6 years and 7–17 years old patients decreased by
25.72% and 26.20% respectively. Conversely, rates for the
groups of 18–64 years and ≥65 years showed an increase
of 1.94% and 42.94% respectively.
There was no significant difference between males and
females in terms of change over time in overall ArADE
admissions (p > 0.01, Table 2). When specific age groups
were examined, there was a significantly larger increase
in rate of ArADE admissions among males than their
female counterparts for the group of 18 to 64 years old
(p < 0.01). Specifically, ArADE admissions in female and
male patients increased by 14.8% and 22.9% respectively.
Changes in rates in female and male patients were 1.3%
and 3.1% respectively. There was no significant differ-
ence found between males and females for the other
three groups (≤6, 7–17, and ≥65 years old) in terms of
change (p > 0.01).
As shown in Table 3, there was a significant larger in-
crease in ArADE admissions among patients from areas
of bottom-half income than their top-half counterparts
(p < 0.01). Specifically, ArADE admissions in bottom-half
areas increased by 113.7% while ArADE admissions in
top-half areas decreased by 25.2% respectively. Changes
over time were significantly different between the
bottom-half areas and top-half areas for the groups of 7
to 17 years old, 18 to 64 years old and ≥65 years old
(p < 0.01). For the group of 7 to 17 years old, ArADE
admissions changed by 61.6% and -43.4% in the areas
of bottom-half income and areas of top-half income
respectively. For the group of 18 to 64 years old,
ArADE admissions changed by 122.5% and -25.5% in
the areas of bottom-half income and areas of top-half
income respectively. For the group of ≥65 years old,
ArADE admissions changed by 122.5% and 38.9% in
the areas of bottom-half income and areas of top-half
Table 1 Changes in ArADE admissions by age
2001 2011 Percentage Change
in admissions ratea
N (all admissions) 37,185,482 38,560,751 3.7b
ArADE admissions* 17,375 20,588 15.32
Age (years)†
≤ 6 272 233 -25.72
7–17 1,863.4 1,586 -26.20
18–64 14,280 16,787 1.94
≥ 65 656.37 1,082 42.94
aPercentage changes in rate. Rate was calculated by dividing ArADE admissions or
admissions in each age group by total number of all admissions of the respective
year. Percentage change was calculated using 2001 rate as the base
bRate change in number of admissions from 2001 to 2011 using 2001 as the base
*p ≤ 0.01, which indicates there is significant difference between the change in
ArADE admissions and the change in overall hospital admissions in the U.S
†p ≤ 0.01, which indicates changes between different age groups are
significantly different
Note: The numbers by age groups were counted after excluding records with
missing data. Hence the sum of different age groups is less than the total number
ArADE admissions
Table 2 Changes in ArADE Admissions from 2001 to 2011 by age and sex
2001 2011 Percentage change in admissions ratea
Females Males Females Males Females Males
ArADE admissions 11,342 5,730 12,854 6,834 13.3b 19.3b
ArADE admissions by age group
≤ 6 150 122 130 103 -23.5 -29.2
7–17 1,325 538 1,155 430 -23.1 -33.0
18–64* 9,410 4,871 10,800 5,988 1.3 3.1
≥ 65 457 199 769 313 48.5 31.9
aPercentage changes in rate. Rate was calculated by dividing ArADE admissions in the corresponding subgroup by the corresponding column total of ArADE admissions
of the respective year. Percentage change was calculated using 2001 rate as the base
bRate change in number of ArADE admissions from 2001 to 2011 using 2001 as the base
*p ≤ 0.01, which indicates change in rates over time were significantly different between males and females in the specific age group
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income respectively. However, the changes in rates in
the corresponding income groups were much greater
for the ≤6 and ≥65 years old groups than the 7 to 17 and
18 to 64 years old groups. Specifically, for the ≤6 years old
group, changes in rates in bottom-half and top-half areas
were -49.8% and -5.7% respectively. For the ≥65 years old
group, changes in rates in the bottom-half and top-half
areas were 4.2% and 85.7% respectively.
The changes in ArADE admissions from 2001 to 2011
by age and urban/rural setting of a hospital are presented
in Table 4. There was a 22.8% increase in ArADE admis-
sions among urban hospitals and a 14.6% decrease among
rural hospitals. This change was statistically significant
(p < 0.01). Changes over time were significantly differ-
ent between the urban and rural hospitals for all age
groups as presented in Table 4 (p < 0.01). The changes
in rates among urban and rural hospitals showed simi-
lar direction (increase or decrease) for each age group.
As shown in Table 5, the mean LOS of ArADE admis-
sions were 2.18 days in 2001. Change in mean LOS of
ArADE admissions from 2001 to 2011 was 0.63 days,
which was statistically significant (p < 0.01). Changes in
mean LOS of ArADE admissions for the 7–17 years old
and 18–64 years old groups were statistically significant,
which was 0.42 and 0.64 days respectively.
Mean hospital charges more than doubled from
$8,456.2 to $21,572.5 (p < 0.01, Table 6) for ArADE
admissions when all age groups were considered. When
the different age groups were analyzed separately,
changes in mean hospital charges were statistically
significant for all four age groups (p < 0.01).
Discussion
The present study was the first to examine the change in
ArADE hospital admissions over time (between 2001
and 2011) in the U.S. First, there was a significantly
higher increase in ArADE admissions as compared to
all-cause admissions. According to data published by
Agency for Healthcare Research and Quality and IMS
Health, the number of prescriptions for antidepres-
sants increased by approximately 98% from 2001 to
2011 [15, 16]. Thus, the percentage increase in ArADE
admissions is less than the percentage increase in
Table 3 Changes in ArADE Admissions from 2001 to 2011 by age and neighborhood income
2001 (income) 2011 (income) Percentage change in admissions ratea
Bottom 50% Top 50% Bottom 50% Top 50% Bottom 50% Top 50%
ArADE admissions* 4,972 12,100 10,624 9,054 113.7b -25.2b
ArADE admissions by age group
≤ 6 109 163 117 115 -49.8 -5.7
7–17† 509 1,354 820 766 -24.6 -24.4
18–64† 4,150 10,131 9,233 7,545 4.1 -0.5
≥ 65† 204 452 454 628 4.2 85.7
aPercentage changes in rate. Rate was calculated by dividing ArADE admissions in the corresponding subgroup by the corresponding column total of ArADE admissions
of the respective year. Percentage change was calculated using 2001 rate as the base
bRate change in number of ArADE admissions from 2001 to 2011 using 2001 as the base
*p ≤ 0.01, which indicates there is a significant difference between areas of bottom-half income and top-half income with regard to change in ArADE admissions
†p ≤ 0.01, which indicates change in rates over time were significantly different between areas of bottom-half income and top-half income in the specific age group
Table 4 Changes in ArADE Admissions from 2001 to 2011 by age and urban/rural setting of a hospital
2001 2011 Percentage change in admissions ratea
Urban Rural Urban Rural Urban Rural
ArADE admissions* 13,677 3,395 16,789 2,899 22.8b -14.6b
ArADE admissions by age group
≤ 6† 190 82 223 10 -4.4 -85.8
7–17† 1,499 364 1,378 208 -25.1 -33.1
18–64† 11,443 2,838 14,214 2,573 1.2 6.2
≥ 65† 545 111 974 108 45.6 13.9
aPercentage changes in rate. Rate was calculated by dividing ArADE admissions in the corresponding subgroup by the corresponding column total of ArADE admissions
of the respective year. Percentage change was calculated using 2001 rate as the base
bRate change in number of ArADE admissions from 2001 to 2011 using 2001 as the base
*p ≤ 0.01, which indicates there is a significant difference between urban and rural areas with regard to change in ArADE admissions
†p ≤ 0.01, which indicates change in rates over time were significantly different between areas of bottom-half income and top-half income in the specific age group
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prescriptions. However, the greater increase in ArADE ad-
missions than all-cause admissions suggests that ArADE
has become a bigger social and economic burden in the
U.S. Other factors that may explain the overall increase in
ArADE admissions include change in antidepressants
most widely prescribed and the introduction of new anti-
depressants onto the market [17–19].
This study found that the overall increase in ArADE
admissions is mainly attributed to increases among
adult patients, since patients 17 or younger exhibited
decrease in ArADE admissions. The group of 65 or
older experienced the greatest increase in both absolute
numbers and relative proportions to the total ArADE
admissions (rates). According to a study by Olfson and
Marcus [18], the rate of antidepressant use over time
has had similar increase across all age groups. Increase
in the U.S. population from 2000 to 2010 has been
2.6%, 11.6% and 15.1% for < =17, 18 to 64, and > =65
age groups respectively [20]. Thus, the change in size of
population alone cannot explain the different trends in
ArADE admissions. The greatest increase in ArADE
admissions among patients 65 or older may be due to
increased number of prescriptions, drug-drug interac-
tions because of polypharmacy, weaker physical condi-
tion than younger patients, and comorbidities. More
investigation on the potential causes of these different
trends is needed.
In addition to unequal changes between age groups,
the change in ArADE admissions from 2001 to 2011 was
also unequal between sexes, areas of different income
levels and urban-rural settings. Olfson and Marcus
found that male patients diagnosed with depression had
a greater increase in prescriptions per person [20], which
may partially explain our finding that male patients had
a higher increase in ArADE admissions within the
10 years time period. A closer look at the data showed
that the higher increase among males than females oc-
curred in patients 18–64 years old.
When all age groups were considered, areas of the
highest income quartile experienced a decrease in
ArADE admissions while areas of the lowest income
quartile experienced almost a five-fold increase (quartile
results were not presented in the tables for simplification
purpose). Among patients 65 years or older, areas of the
highest income quartile experienced the least increase
while the lowest income quartile experienced almost a
six-fold increase. This is contrary to the findings by
Zhang and colleagues [21] who found that socio-
economic disadvantage is not associated with a higher
risk of adverse drug reactions. The different trends in
areas with different income levels observed in the
present study may be partially explained by what was
found by Lorant and colleagues [22]. In a meta-analysis,
Lorant and colleagues reported that individuals with
lower socio-economic status (SES) had higher risk of
new depression episodes than those with higher SES and
the difference in risk of persisting depression between
low and high SES individuals was even greater. However,
such difference in risk of depression cannot completely
explain the different trends over time found in the
present study. Other potential factors may include poor
quality of care to patients with depression and less ac-
cess to timely care in lower-income patients, which
could lead to greater increase in ArADE admissions.
The greater increase in ArADE admissions among
urban patients in comparison to rural patients can be
partially explained by the greater increase in urban
population. According to the U.S. census bureau [23],
Table 5 Length of stay (LOS) of ArADE admissions in 2001 and
2011
Mean (SD, Median) Change in
mean LOS2001 2011
LOS of all ArADE admissions 2.18 (6.31, 1) 2.81 (7.74, 2) 0.63*
LOS by age group
≤ 6 0.89 (1.30, 1) 1.12 (1.78, 1) 0.23
7–17 1.46 (2.71, 1) 1.88 (5.38, 1) 0.42*
18–64 2.20 (6.40, 1) 2.84 (7.74, 2) 0.64*
≥ 65 4.17 (9.59, 2) 3.97 (10.16, 2) -0.20
*p < 0.01
Table 6 Hospital Charge for ArADE admissions in 2001 and 2011
Mean (SD, median) Change in mean
hospital charge2001($) 2011($)
Hospital charge of all ArADE admissions (SD, median) 8,456.2 (34,996.2, 5,022.0) 21,572.5 (94,128.3, 11,899.0) 13,116.3*
Hospital charge by age group (SD, median)
≤ 6 2,535.0 (3,116.3, 1,354.4) 6509.8 (11,256.9, 3,594.8) 3,974.8*
7–17 4,931.8 (11,650.1, 2,666.0) 11,975.7 (43,338.3, 6,656.6) 7,043.9*
18–64 8,681.3 (35,751.9, 5,111.5) 22,151.5 (96,347.3, 11,909.1) 13,470.2*
≥ 65 16,038.4 (55,787.2, 9,078.9) 29,990.7 (115,441.0, 14,979.1) 13,952.3*
*p < 0.01
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urban population grew by 12.1% while rural population
grew only 0.3% from 2000 to 2010. However, the magni-
tude of increase in ArADE admissions among urban
patients is much greater than the population growth.
Overall, both mean LOS and mean hospital charge for
ArADE admissions from 2001 to 2011 showed an in-
crease from 2001 to 2011. Combining with the increased
number of ArADE admissions, this suggests that ArADE
incurred an increased burden to the society. This study
also showed that different age groups experienced differ-
ent magnitudes of increase in LOS and hospital charges
over the time period. While LOS of ArADE admissions
increased only slightly when all age groups were consid-
ered together, the average and median hospital charges
more than doubled. This can partially be attributed to
medical cost inflation, which rose by 47.1% in the same
time period [24]. The additional increase in hospital
charges may be due to the change in case mix associated
with greater share of elderly patients and patients who
did not receive timely care among other factors. As
shown in the results, mean LOS for patients 65 or older
actually decreased (although insignificant) while mean
hospital charge for that group increased significantly.
The present study has several limitations. In this study,
it was assumed that diagnosis recorded in the first ICD-
9 code of a hospital admission is the primary diagnosis
that caused the admission. Instances of illicit drug use
and cases of intentional harm or self-inflicted injury
were identified based on ICD code and excluded from
the study.. However, we acknowledge that ICD codes are
optional for billing purposes and notoriously non-
sensitive when used for ADE outcomes of interest.
Especially in the case of self-assault or attempted suicide,
clinicians may be wary to document such information
due to legal and social implications or simply due to lack
of background information on the patients. Thus,
although some cases of intentional self-harm were ex-
cluded from the analyses; however there is a possibility
of misclassification bias. We were also limited by the in-
formation available in the HCUP databases. Several
states do not report the race variable. Hence the inci-
dence of ArADE admissions and differences between
different racial groups couldn’t be compared. Addition-
ally, individual patients cannot be followed on different
admissions to a hospital due to the lack of a common ID
for the same patient. As a result, a patients with multiple
ArADE admissions to the included hospitals was
counted as multiple patients. Also, it would be note-
worthy to mention that there has been a great deal of
awareness and research regarding ADEs in general since
early 2000. Provider awareness to more appropriately
diagnose and code these related conditions (for treat-
ment and billing purposes) could therefore account for
the perceived ‘higher’ incidence in 2011.
Conclusion
ArADE hospital admissions had significant increase from
2001 to 2011 in the United States especially in the elderly,
areas of lower-income and urban patients. The increases
have incurred a greater economic burden to the society.
Further research is needed to investigate the root causes
of these increases and the large increase in hospital
charges. It would also be beneficial to examine whether
similar trends among the different socio-demographic
groups exists for hospital admissions related to ADEs of
other drug classes. Currently, various CDC and FDA led
programs are being executed with the goal of increasing
awareness to medication safety and reducing ADEs. Prob-
ably, actions to bolster these initiatives and implementa-
tion of novel public health actions are needed to address
the increase in ArADE admissions.
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